Meitheal Pharmaceuticals has Micafungin for Injection, Now Available
Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Micafungin for Injection in 50 mg per vial in a single-dose vial and 100 mg per vial in a single-dose vial.
Meitheal will offer Micafungin for Injection in packs of 10 vials for both presentations.
ABOUT MICAFUNGIN FOR INJECTION
Micafungin for Injection is indicated in adult and pediatric patients for the treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older. For full prescribing information, and safety information, including boxed warning, please click on the following link.
Learn more about who we are and what we do at www.meithealpharma.com